Matches in Nanopublications for { ?s ?p "[A case for LANCL2-based drug discovery and development is also illustrated by the anti-inflammatory activity of novel LANCL2 ligands such as NSC61610 against inflammatory bowel disease and influenza-driven inflammation in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP922046.RAZ9VitxoC2UAaWrA80-sCVm0dyYzK-3SLkb_SEfg6Ci0130_assertion description "[A case for LANCL2-based drug discovery and development is also illustrated by the anti-inflammatory activity of novel LANCL2 ligands such as NSC61610 against inflammatory bowel disease and influenza-driven inflammation in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP922046.RAZ9VitxoC2UAaWrA80-sCVm0dyYzK-3SLkb_SEfg6Ci0130_provenance.
- assertion description "[A case for LANCL2-based drug discovery and development is also illustrated by the anti-inflammatory activity of novel LANCL2 ligands such as NSC61610 against inflammatory bowel disease and influenza-driven inflammation in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A case for LANCL2-based drug discovery and development is also illustrated by the anti-inflammatory activity of novel LANCL2 ligands such as NSC61610 against inflammatory bowel disease and influenza-driven inflammation in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP922047.RAi-ysTlBtncs7oSp5GuOI9S-MJaNZ2CBcpbq8RQuylWg130_assertion description "[A case for LANCL2-based drug discovery and development is also illustrated by the anti-inflammatory activity of novel LANCL2 ligands such as NSC61610 against inflammatory bowel disease and influenza-driven inflammation in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP922047.RAi-ysTlBtncs7oSp5GuOI9S-MJaNZ2CBcpbq8RQuylWg130_provenance.
- NP1163803.RAppY24bTYUMSskqTGgLRUOj3wiLfE1NRQ38HDC9VzEzk130_assertion description "[A case for LANCL2-based drug discovery and development is also illustrated by the anti-inflammatory activity of novel LANCL2 ligands such as NSC61610 against inflammatory bowel disease and influenza-driven inflammation in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1163803.RAppY24bTYUMSskqTGgLRUOj3wiLfE1NRQ38HDC9VzEzk130_provenance.
- NP1163802.RA4V_lyrkqO-eH4fZIR0Re7AOzuJOSd9CZBKxuf1vJQcw130_assertion description "[A case for LANCL2-based drug discovery and development is also illustrated by the anti-inflammatory activity of novel LANCL2 ligands such as NSC61610 against inflammatory bowel disease and influenza-driven inflammation in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1163802.RA4V_lyrkqO-eH4fZIR0Re7AOzuJOSd9CZBKxuf1vJQcw130_provenance.